Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
SULFONYL HYDRAZINE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/153326
Kind Code:
A1
Abstract:
The present invention relates to a sulfonyl hydrazine compound and a use thereof as a medicament for use in treating hepatitis B. Specifically, the present invention discloses a compound which may act as an HBV inhibitor and which has the structure represented by chemical formula A, or a stereoisomer or tautomer thereof, or a pharmaceutically acceptable salt, a hydrate or a solvent thereof. For the definitions of each group, see the description for detail. The present invention also relates to a pharmaceutical composition containing said compound and a use thereof in the treatment of hepatitis B.

Inventors:
WANG ZHE (CN)
WANG XIAOGUANG (CN)
LU CENBIN (CN)
Application Number:
CN2018/076728
Publication Date:
August 30, 2018
Filing Date:
February 13, 2018
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI LONGWOOD BIOPHARMACEUTICALS CO LTD (CN)
International Classes:
C07D513/04; A61K31/407; A61P31/20; C07D401/12; C07D405/14; C07D515/04
Domestic Patent References:
WO2017001655A12017-01-05
Foreign References:
CN105102451A2015-11-25
CN105980378A2016-09-28
CN105452220A2016-03-30
Attorney, Agent or Firm:
XU & PARTNERS, LLC. (CN)
Download PDF: